Antimicrobial Susceptibility of Neisseria gonorrhoeae in Bangladesh (2014 Update)

Researchers from icddrb, save the children Bangladesh and Johns Hopkins university in the USA came together to collaborate in this paper. The paper aims to orient readers on the new finding on Neisseria gonorrhoeae species in Bangladesh. Which is becoming resistant to many organisms. Approximately half of the study participants were diagnosed with STIs previously (data not shown), using the syndromic approach, and many had received antimicrobial therapy, which could be the reason for the low recovery of N. gonorrhoeae strains. This is of relevance as the national syndromic guidelines for STI management in Bangladesh recommend treating gonorrhea and chlamydia with cefixime and azithromycin (6). However, with emerging resistance of N. gonorrhoeae to cefixime and ceftriaxone (8, 9), gonorrhea management guidelines are under scrutiny globally (10, 11). These current data from Bangladesh add to the global antimicrobial resistance data on N. gonorrhoeae and highlight the need to update the national guidelines for STI management in Bangladesh.

Full text article available at:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914670/pdf/zac4418.pdf